Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.665
Change: 0.00 (0.00%)
Spread: 0.665 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IFRS Consolidated Financial Statements- FY22

28 Apr 2023 14:26

RNS Number : 9235X
EFG-Hermes Holdings SAE
28 April 2023
 

http://www.rns-pdf.londonstockexchange.com/rns/9235X_1-2023-4-28.pdf

EFG Hermes Reports IFRS Consolidated Financial Statements for the Year Ended 31 December 2022

 

For the full financial Statements please click on the link on top of the page

 

Consolidated statement of financial position

As at 31 December

 

 

2022

2021

EGP

EGP

 

Restated

Assets

Notes

Cash and cash equivalents

5

 26,214,250,479

30,876,257,819

Funded facilities to customers

8

 13,904,711,801

10,454,979,766

Banking loans and facilities (aiBank)

8.1

 19,317,430,427

9,544,916,760

Accounts receivable

7

 5,569,133,136

5,611,375,904

Investments at fair value through profit and loss

6

 6,772,893,362

8,002,539,778

Investments at fair value through OCI

9

 14,080,120,999

16,820,480,365

Investments at amortized cost

12

 11,518,692,377

10,050,278,918

Assets held for sale

11

 349,701,081

310,745,145

Equity accounted investees

10

 606,432,818

461,315,552

Investment properties

13

 118,984,442

125,529,472

Property and equipment

14

 1,636,042,509

1,522,312,110

Goodwill and other intangible assets

15

 1,954,749,801

993,839,079

Deferred tax assets

22

 64,486,447

41,521,424

Other assets

16

 3,401,909,847

2,564,263,111

Total assets

105,509,539,526

 

97,380,355,203

Liabilities

Due to banks and financial institutions

17

 12,371,835,820

17,736,580,111

Customer deposits

18

 48,130,171,764

38,564,737,371

Loan and borrowings

24

 4,996,029,063

5,501,069,487

Creditors and other credit balances

21

 4,982,664,616

3,531,967,772

Accounts payable - customers credit balances FVTPL

19

379,039,443

3,890,060,348

Accounts payable - customers credit balances

 9,595,446,350

8,537,833,096

Issued bonds

20

 500,000,000

550,000,000

Provisions

23

 903,715,808

690,001,941

Current tax liability

 473,873,472

363,572,503

Deferred tax liabilities

22

 800,661,223

410,044,804

Total liabilities

 83,133,437,559

79,775,867,433

Equity

Share capital

25

 5,838,424,030

4,865,353,355

Legal reserve

 867,454,520

840,272,556

Share premium

 1,668,623,811

1,668,623,811

Other reserves

 3,125,555,888

783,420,592

Retained earnings

 7,460,139,693

6,486,918,967

Equity attributable to owners of the Group

 

 

 18,960,197,942

14,644,589,281

Non - controlling interests

26

 3,415,904,025

2,959,898,489

Total equity

 22,376,101,967

17,604,487,770

Total liabilities and equity

105,509,539,526

 

97,380,355,203

 

 

These financial statements were approved and authorised for issue on 28 April 2023 and signed by:

 

 

 

 

 

 

Mona Zulficar

Chairperson

Karim Awad

Group Chief Executive Officer

 

 

 

The accompanying notes form an integral part of these consolidated financial statements.

 

Consolidated statement of profit or loss

For the year ended 31 December

 

 

Notes

2022

 

2021

 

 

EGP

 

EGP

 

 

 

 

Restated

Interest income

32

9,295,888,885

4,416,355,205

Interest expense

32

 (5,698,004,648)

(1,831,314,272)

Net interest income

 

3,597,884,237

 

2,585,040,933

Fee and commission income

32

4,804,815,709

3,395,050,747

Fee and commission expense

32

 (508,239,556)

(344,114,579)

Net fee and commission income

4,296,576,153

 

3,050,936,168

Securities' losses for investments at FVTPL

32

 (847,026,822)

(7,302,092)

Changes in the fair value of investments at FVTPL

6-32

923,031,019

(76,153,571)

Dividend income

32

5,660,968

31,853,072

Other revenues

28

159,190,766

146,867,227

Gains on dereceognition of financial assets at amortized cost

32

222,309,757

88,347,943

Impairment loss on financial assets - net of recoveries

29

 (726,510,890)

(137,995,100)

Foreign currencies exchange differences

32

 2,495,674,925

234,140,416

Gains on selling assets held for sale

32

 5,486,779

3,864,407

Share of proft/(loss) from equity accounted investees

32

 76,562,049

(14,173,369)

Bargain purchase gain

15

 -

97,562,892

 

 

 10,208,838,941

 

6,002,988,926

General and administrative expenses

31

 (6,541,863,982)

(3,796,051,268)

Financial guarantee provision

23

 (21,174,484)

(5,673,313)

Impairment loss on goodwill and intangible assets

32

 (10,239,218)

(16,034,698)

Provisions

23

 (156,889,673)

(96,968,478)

Depreciation and amortisation

31.2

 (296,470,780)

(196,292,200)

Profit before tax

 3,182,200,804

1,891,968,969

Income tax expense

30

 (1,103,724,498)

(350,195,700)

Profit for the year

 2,078,476,306

 

1,541,773,269

Attributable to:

 

 

 

Shareholders of the Holding Company

1,724,108,570

1,425,807,709

Non-controlling interests

354,367,736

115,965,560

2,078,476,306

 

1,541,773,269

 

 

Earnings per share:

 

Basic earning per share - EGP

34

1.48

 

1.27

 

Diluted earnings per share - EGP

34

1.48

 

1.27

 

 

 

The accompanying notes form an integral part of these consolidated financial statements.

 

Consolidated statement of comprehensive income

For the year ended 31 December

 

 

 

Notes

2022

 

2021

 

 

EGP

 

EGP

 

 

 

 

Restated

Profit for the year

 

 2,078,476,306

1,541,773,269

Other comprehensive income items:

Items that may be reclassified to the consolidated statement of profit or loss

Foreign operations - foreign currency translation differences

3,210,783,015

(15,450,147)

Foreign currency translation differences - reclassified to profit or loss

(852,751,863)

(167,306,760)

Net losses on investments in debt instruments at FVOCI- net change in fair value

(157,786,834)

(10,639,480)

Investments at fair value through OCI - net change in fair value - reclassified to profit or loss

(3,015,600)

34,043,158

Tax relating to such items

22

24,443,416

(930,181)

 

2,221,672,134

(160,283,410)

Items that will not be reclassified to the consolidated statement of profit or loss

Investment at fair value through OCI - reclassified to retained Earnings

(547,139)

(15,659)

Net gains on investments in equity instruments designated at fair value through OCI

49,993,934

10,802,502

Share of other comprehensive income of equity accounted investees

206,189

-

Actuarial gain/(loss) re-measurement of employees' benefits obligations

23

(4,505,067)

971,076

Total other comprehensive income for the year

2,266,820,051

(148,525,491)

Total comprehensive income for the year

4,345,296,357

 

1,393,247,778

 

Attributable to:

 

 

 

Shareholders of the Holding Company

3,842,008,839

1,268,728,563

Non-controlling interests

503,287,518

124,519,215

4,345,296,357

 

 1,393,247,778

 

 

 

For further information:

Investor Relations Department

Email: investor-relations@efg-hermes.com

Tel: +20 (0)2 35356710

Fax: +20 (0)2 3535 7017

 

Group Head of Corporate Strategy & Investor Relations - Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

Fax: +20(0)2 3535 7017

www.efg-hermes.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR SEFFDAEDSEEL
Date   Source Headline
26th Apr 20129:23 amRNSStatement re. Press Comment
25th Apr 20123:45 pmRNSSecond Price Monitoring Extn
25th Apr 20123:40 pmRNSPrice Monitoring Extension
10th Apr 20127:00 amRNSFY2011 Results
28th Mar 20129:36 amRNSStatement re Damas International Limited
26th Mar 20128:49 amRNSStatement re Strategic Alliance with QInvest
19th Mar 201211:07 amRNSStatement re. Press Comment
14th Feb 20129:33 amRNSStatement re CEO Travel Ban
8th Feb 20128:33 amRNSStatement re CEO Travel Ban
6th Feb 20127:42 amRNSStatement re - CEO Travel Ban
17th Jan 20123:45 pmRNSSecond Price Monitoring Extn
17th Jan 20123:40 pmRNSPrice Monitoring Extension
16th Nov 20119:28 amRNS3rd Quarter Results
10th Oct 20113:45 pmRNSSecond Price Monitoring Extn
10th Oct 20113:40 pmRNSPrice Monitoring Extension
4th Oct 20119:53 amRNSStatement re. Press Comment
19th Sep 20113:45 pmRNSSecond Price Monitoring Extn
19th Sep 20113:40 pmRNSPrice Monitoring Extension
19th Sep 20112:00 pmRNSStatement re Bonus Shares Distribution
2nd Sep 20113:40 pmRNSPrice Monitoring Extension
15th Aug 20117:00 amRNS2nd Quarter results
11th Aug 20113:45 pmRNSSecond Price Monitoring Extn
11th Aug 20113:40 pmRNSPrice Monitoring Extension
1st Aug 20113:45 pmRNSSecond Price Monitoring Extn
1st Aug 20113:40 pmRNSPrice Monitoring Extension
19th Jul 20113:45 pmRNSSecond Price Monitoring Extn
19th Jul 20113:40 pmRNSPrice Monitoring Extension
13th Jul 20113:45 pmRNSSecond Price Monitoring Extn
13th Jul 20113:40 pmRNSPrice Monitoring Extension
6th Jul 201111:53 amRNSRegulatory Approval
27th Jun 20113:45 pmRNSSecond Price Monitoring Extn
27th Jun 20113:40 pmRNSPrice Monitoring Extension
15th Jun 20119:28 amRNS1st Quarter Results
13th Jun 201110:36 amRNSEGM & AGM Statement
6th Jun 20117:00 amRNSTreasury Stock
25th May 20119:29 amRNSNotice of AGM & EGM
10th May 20113:40 pmRNSPrice Monitoring Extension
5th May 20113:45 pmRNSSecond Price Monitoring Extn
5th May 20113:40 pmRNSPrice Monitoring Extension
4th May 20113:40 pmRNSPrice Monitoring Extension
28th Apr 20113:40 pmRNSPrice Monitoring Extension
27th Apr 20111:12 pmRNSStatement re Board of Directors
26th Apr 20113:40 pmRNSPrice Monitoring Extension
26th Apr 201110:32 amRNSStatement re Board of Directors
18th Apr 20119:51 amRNSDirectorate Change
30th Mar 20112:19 pmRNSStatement re news published on the company
30th Mar 20119:47 amRNSAnnual Financial Report
29th Mar 20115:00 pmRNSDirectorate Change
14th Feb 20117:10 amRNSStatement re clarification of ownership
10th Feb 20113:45 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.